Analysis of total metabolites in three types of Pulsatilla medicinal herbs
-
P. chinensis has been documented in medicinal texts since the Shen Nong Ben Cao Jing and has historically been the mainstream medicinal variety. P. cernua is recorded in the medicinal diagrams of the Japanese herbal text Ben Cao Tu Pu, written during the Ming and Qing dynasties. Additionally, it is listed in the Chinese herbal medicine standards of Jilin and Liaoning provinces, where it is used similarly to P. chinensis. P. chinensis var. kissii, a variant of P. chinensis commonly found and used locally in Dalian, Anshan, and Liaoyang cities in Liaoning province. Its distribution overlaps significantly with that of P. chinensis and P. cernua in Liaoning province, often leading to cases of mistaken harvesting and misuse in the wild. To better understand the medicinal value of P. chinensis var. kissii and compare its metabolites with those of the other two recorded medicinal Pulsatilla species, extensive targeted metabolite analysis was conducted using UPLC–MS/MS. A total of 1,558 metabolites were identified. In the negative ion mode, four ion modes were used, including [M-H]−, [M+CH3COO]−, [M-Na]−, and [M+CH3COOH-H]−. A total of 748 metabolites, encompassing 143 primary metabolites and 605 secondary metabolites, were detected. Fifteen triterpenoid saponin components, including pulsatilloside C, anemoside B4, anemoside A3, pulsatilla saponin D, and hederacoside D, were identified and found to be distributed across all three types of Pulsatilla medicinal herbs. In the positive ion mode, six ion modes were used, including [M+H]+, [M]+, [M+NH4]+, [M-H2O+Na]+, [M+Na]+, and [M-H2O+H]+. A total of 810 metabolites, encompassing 249 primary metabolites and 561 secondary metabolites, were detected. Thirty-two triterpenoid saponin components were identified in the positive ion mode, including hederacoside C, dipsacoside B, mutong saponin A, and kalopanaxsaponin H, all of which were distributed across the three Pulsatilla medicinal herbs.
A comparison of the metabolite detection results of the three Pulsatilla medicinal herbs revealed several unique metabolites in P. chinensis var. kissii, P. chinensis, and P. cernua. Specifically, quercetin 3-O-apiryl (1→2) galactoside, 3',5',5,7-tetrahydroxy-4'-methoxyflavonone-3'-O-glucoside, 3-O-ferulic acid quinic acid (a phenolic acid), and guanidine (an alkaloid) were present in P. chinensis var. kissii but not in the other two types of Pulsatilla within the same population. In addition, the triterpenoid saponins 3-O-rhamnosyl (1→2) arabinose glycosyl-28-O-glucoside and ivy saponin-3-O-α-L-rhamnose (1→2)-(β-D-glucose group (1→4))-α-L-arabinose, as well as the flavonoids tamarixin, paeonol neoglycoside, peony glycoside, and 2,5-dimethyl-7-hydroxychromone glucoside, were unique to P. chinensis. Unique metabolites in P. cernua included the phenolic acid salvianolic acid I, hairy flower glycoside, and alkaloid isocyanidin. These unique metabolites can facilitate the differentiation between the three species of Pulsatilla. Using the 1,558 detected metabolites, a CA was performed on the nine samples representing the three types of Pulsatilla. The results indicated that the growth environment affected the overall clustering of metabolites. Pulsatilla samples of the same variety did not cluster together, whereas those of different Pulsatilla varieties from the same population tended to cluster together. These results are illustrated in Fig. 1.
Multivariate analysis of identified metabolites
-
To investigate differences in metabolite contents among the three types of Pulsatilla medicinal herbs, particularly between P. chinensis var. kissii and the other two types of P. chinensis, PCA was conducted on the data from 1,558 metabolites. The PCA results revealed that the three Pulsatilla medicinal herbs clustered together, with the model variance explained by the PCA 1 and PCA 2 axis being 39.72% (Fig. 2). The metabolomic differences along the PCA1 axis among the three Pulsatilla species were not significant. This analysis highlighted the correlation between the metabolite profiles of the three groups and varieties of Pulsatilla.
To further analyze and determine differences in the metabolite composition among samples within the group, supervised orthogonal signal correction combined with partial least squares discriminant analysis (OPLS-DA) was used for better differentiation between the groups, as shown in Fig. 3. In this study, the OPLS-DA model was used to compare the metabolite content of paired samples and evaluate the relationships between P. chinensis var. kissii and P. chinensis (R2X = 0.469, R2Y = 0.997, Q2 = 0.492); P. chinensis var. kissii and P. cernua (R2X = 0.392, R2Y = 0.999, Q2 = 0.429); and P. cernua and P. chinensis (R2X = 0.468, R2Y = 0.993, Q2 = 0.468).
CA of differential metabolites in the three medicinal herbs of the genus Pulsatilla
-
Using the differential metabolites identified in OPLS-DA, a CA was performed on the three types of Pulsatilla medicinal herbs. The analysis revealed that triterpenoid saponin components, such as anemoside B4, were present in higher concentrations in P. chinensis than in the other two herb types. The results of this analysis are presented in Fig. 4.
Analysis of differential metabolites between P. chinensis and P. chinensis var. kissii
-
Based on the t-test results with p values < 0.05 and variable importance (VIP) values ≥ 1.0, a total of 278 significantly different metabolites were identified between P. chinensis var. kissii and P. chinensis. Among these, the contents of 192 metabolites were higher in P. chinensis var. kissii than in P. chinensis, whereas those of 86 metabolites were lower in P. chinensis var. kissii. The 278 different metabolites were classified into 12 categories, with terpenoids being the most represented (65 metabolites), followed by phenolic compounds (60 metabolites). Among the differential metabolites in the terpenoid category, 28 were triterpenoid saponins. Of these, 10 compounds were upregulated in P. chinensis var. kissii, most of which are pentacyclic triterpenoid compounds of the oleanolic acid type, such as oleanol-3-O-glucoside, oleanol-3-O-glucosyl (1-2) glucoside, and dipsacussaponin B. By contrast, 18 compounds were downregulated, with the contents of saponin compounds such as anemoside A3, anemoside B4, and anemoside C being lower in P. chinensis var. kissii than in P. chinensis. In addition, hederacoside C and hederacoside D were significantly downregulated in P. chinensis var. kissii. The results are illustrated in Fig. 5.
Analysis of differential metabolites between the medicinal materials of P. chinensis var. kissii and P. cernua
-
Based on the t-test results, with p values < 0.05 and VIP values ≥ 1.0, a total of 304 significantly different metabolites were identified in the comparison between P. chinensis var. kissii and P. cernua. Among these, the contents of 165 metabolites were higher and those of 139 metabolites were lower in P. chinensis var. kissii than in P. cernua. The 304 metabolites were classified into 12 categories, with terpenoids accounting for the largest proportion (66 metabolites), followed by phenolic acids (42 metabolites). Within the terpenoid category, 20 triterpenoid saponin compounds exhibited differential expression. Of these, 13 compounds were upregulated in P. chinensis var. kissii, most of which were anemoside compounds, namely anemoside A3, anemoside B4, and anemoside C, with significant upregulation compared with P. cernua. In addition, Yusaponin I and mutongsaponins from other regions were upregulated. Conversely, seven compounds were downregulated, including dipsacoside B, Udosaponin A methyl ester, and hederacoside D; all these compounds exhibited significant downregulation compared with that in P. cernua. The results are presented in Fig. 6.
Analysis of differential metabolites between P. cernua and P. chinensis
-
Based on the t-test results, with p values < 0.05 and VIP values ≥ 1.0, a total of 400 significantly different metabolites were identified between P. cernua and P. chinensis. Among these, the contents of 231 metabolites were higher in P. cernua than in P. chinensis, whereas those of 169 metabolites were lower in P. cernua. The 394 metabolites were classified into 12 categories, with terpenes accounting for the largest proportion (89 metabolites), followed by phenolic compounds (76 metabolites). In the terpenoid category, 32 triterpenoid saponin compounds exhibited differential expression. Of these, 13 compounds, including dipsacoside B, dipsacussaponin B, oleanol-3-O-glucoside, and anemoside D, were upregulated in P. cernua. Conversely, 19 compounds, including anemoside A3, anemoside B4, and anemoside C, were downregulated in P. cernua. The results are presented in Fig. 7.
KEGG pathway enrichment analysis of differential metabolites
-
KEGG pathway enrichment analysis was conducted to determine differences in the metabolic pathways between the groups P. chinensis var. kissii and P. chinensis. The KEGG database is a valuable resource that allows researchers to study genes, gene expression profiles, and metabolite content within an integrated network. As the primary public database related to pathways, KEGG provides queries for various metabolic pathways, including the metabolism of carbohydrates, nucleotides, amino acids, and the biodegradation of organic matter. It not only outlines all possible metabolic pathways but also provides comprehensive annotations of the enzymes catalyzing each step, including amino acid sequences and Protein Data Bank (PDB) library links. These functions make the KEGG database a powerful tool for metabolic analysis and metabolic network research in different organisms. Based on the differential metabolites identified, we conducted the KEGG pathway enrichment analysis. The rich factor is defined as the ratio of the number of differential metabolites in a given pathway to the total number of metabolites annotated in that pathway; the higher the rich factor, the greater the degree of enrichment. Moreover, p values determined using a hypergeometric test indicated the significance of the enrichment (Supplementary Fig. S10). The closer the p-value is to 0, the more significant the enrichment. The size of the dots in the figure represents the number of differential metabolites in each pathway. For clarity, the top 20 pathways selected based on p values have been displayed.
KEGG analysis of differential metabolites between P. chinensis var. kissii and P. chinensis
-
The KEGG classification of differential metabolites revealed that the most enriched pathways between the groups P. chinensis var. kissii and P. chinensis were flavonoid biosynthesis, tyrosine metabolism, and isoquinoline alkaloid biosynthesis. In the flavonoid biosynthesis pathway, five differential metabolites, including trans-5-O-p-coumaryl shikimic acid (a phenolic acid), and flavonoids, such as curcumin, quercetin, catechins, and dihydroquercetin, were identified. The tyrosine metabolism pathway featured four differential metabolites: the phenolic acids danshensu, para-coumaric acid, and rosmarinic acid, as well as the amino acid derivative levodopa. In the isoquinoline alkaloid biosynthesis pathway, three differential metabolites were identified: p-coumaric acid (a phenolic acid), tetrandrine (an alkaloid), and levodopa (an amino acid derivative). The pathway with the highest number of differential metabolites was the biosynthesis of secondary metabolites, including a total of 19 differential metabolites. These metabolites belonged to various categories, including amino acids and derivatives, lipids, phenolic acids, terpenes, organic acids, flavonoids, and alkaloids (Supplementary Fig. S11).
KEGG analysis of different metabolites in medicinal materials of P. chinensis var. kissii and P. cernua
-
The KEGG classification of differential metabolites revealed that the differential metabolites between P. chinensis var. kissii and P. cernua were most significantly enriched in the flavonoid biosynthesis and plant hormone signaling pathways. In the flavonoid biosynthesis pathway, seven differential metabolites were identified, including 5-O-coumaric acid (a phenolic acid), galangin, quercetin, catechin, apigenin, dihydroquercetin, and dihydroquercetin in flavonoids. The plant hormone signaling pathway featured three differential metabolites: jasmonic acid and abscisic acid (organic acids) and jasmonic acid-L-isoleucine (an amino acid derivative). The pathway with the highest number of differential metabolites was the biosynthesis of secondary metabolites, with a total of 25 differential metabolites identified. These metabolites belonged to various categories, including amino acids and derivatives, lipids, nucleic acids and their derivatives, lignans and coumarins, phenolic acids, terpenes, organic acids, flavonoids, and alkaloids (Supplementary Fig. S12).
KEGG analysis of differential metabolites between P. cernua and P. chinensis
-
The KEGG classification of differential metabolites revealed that the most significant enrichment between P. chinensis and P. cernua groups occurred in the flavonoid biosynthesis and ascorbic acid and aldehyde metabolism pathways. In the flavonoid biosynthesis pathway, seven differential metabolites were identified, including trans-5-O-p-coumaroyl shikimic acid and chlorogenic acid (3-O-caffeoyl quinic acid) from the phenolic acids category, as well as quercetin, gallic acid, naringenin, apigenin-8-C-glucoside, and dihydroquercetin from the flavonoids category. In the ascorbic acid and aldehyde metabolism pathway, arachidonic acid (a lipid) was identified as a differential metabolite. The pathway with the highest number of differential metabolites was the biosynthesis of secondary metabolites, with a total of 26 differential metabolites identified. These metabolites belonged to various categories, including amino acids and derivatives, lipids, nucleic acids and their derivatives, lignans and coumarins, phenolic acids, terpenes, organic acids, flavonoids, and alkaloids (Supplementary Fig. S13).